---
title: "Crane | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 493.2 M"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/295015872.md"
datetime: "2026-08-05T21:05:59.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/295015872.md)
  - [en](https://longbridge.com/en/news/295015872.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/295015872.md)
---

# Crane | 8-K: FY2026 Q2 Revenue Misses Estimate at USD 493.2 M

Revenue: As of FY2026 Q2, the actual value is USD 493.2 M, missing the estimate of USD 708.93 M.

EPS: As of FY2026 Q2, the actual value is USD 0.61.

EBIT: As of FY2026 Q2, the actual value is USD 68.9 M.

### Overall Performance

Crane Company reported net sales of $493.2 million for the second quarter of 2026, marking a 22.0% increase compared to $404.4 million in the second quarter of 2025. Organic sales growth contributed 2.8%, or $11.3 million, to this increase.

GAAP net income for the quarter was $35.4 million, a 42.2% increase from $24.9 million in the prior year period, resulting in a net income margin of 7.2%. Adjusted EBITDA was $115.5 million, up 18.0% from $97.9 million in Q2 2025, with an Adjusted EBITDA margin of 23.4%.

#### Cash Flow

Cash from operations for the second quarter of 2026 was $86.7 million, compared to $62.8 million in the same period of 2025. Free cash flow was $73.4 million, an increase from $55.8 million year-over-year. Adjusted free cash flow conversion reached 124.3% in Q2 2026, up from 120.1% in Q2 2025.

#### Segment Performance

##### Security and Authentication Technologies (SAT)

Net sales for SAT were $226.7 million in Q2 2026, an increase of 17.5% from $193.0 million in Q2 2025. Organic sales grew by 9.6%, or $18.5 million. GAAP operating profit increased by 116.1% to $38.9 million from $18.0 million, with the operating profit margin rising to 17.2% from 9.3%. Adjusted EBITDA for SAT was $58.8 million, up 19.0% from $49.4 million, and the Adjusted EBITDA margin was 25.9%.

##### Detection and Traceability Technologies (DTT)

DTT reported net sales of $266.5 million in Q2 2026, a 26.1% increase from $211.4 million in Q2 2025. Organic sales for DTT decreased by -3.4%, or -$7.2 million. GAAP operating profit was $44.0 million, a decrease of -10.2% from $49.0 million, with the operating profit margin at 16.5%. Adjusted EBITDA for DTT was $70.4 million, an increase of 18.7% from $59.3 million, with the Adjusted EBITDA margin at 26.4%.

#### Order Backlog

Total order backlog for Crane Company stood at $755.5 million as of June 30, 2026, an increase from $591.6 million as of June 30, 2025. The SAT segment’s backlog was $498.1 million, and the DTT segment’s backlog was $257.4 million, which includes $124.7 million related to the Antares Vision business acquired in March 2026.

#### Debt

Net debt as of June 30, 2026, was $1,252.6 million, with a net leverage ratio of 2.7.

### Outlook / Guidance

Crane Company is raising its full-year Adjusted EPS guidance to a range of $4.22 to $4.42, up from the previous guidance of $4.10 to $4.40. The company maintains its full-year 2026 sales growth guidance of +15% to +17% and Adjusted EBITDA margin guidance of approximately 24%. Adjusted free cash flow conversion is expected to be between 90% to 110%.

### Related Stocks

- [CR.US](https://longbridge.com/en/quote/CR.US.md)

## Related News & Research

- [Crane director James L. L. Tullis sells 614 shares for $138,150](https://longbridge.com/en/news/295975421.md)
- [Arrowstreet Capital Limited Partnership Decreases Position in Crane $CR](https://longbridge.com/en/news/295316782.md)
- [Skye Bio amends 8-K to set Aug. 24 effective date for reverse stock split](https://longbridge.com/en/news/296471274.md)
- [Vital Farms amends 8-K to add missing Item 5.03 in EDGAR header](https://longbridge.com/en/news/296122466.md)
- [Valion Bio amends 8-K to report final vote tally on reverse stock split approval](https://longbridge.com/en/news/296531983.md)